Pays: Malte
Langue: anglais
Source: Medicines Authority
ETHINYLESTRADIOL, DROSPIRENONE
Mithra Pharmaceuticals S.A Rue Saint-Georges 5, 4000, Liege, Belgium
G03AA12
ETHINYLESTRADIOL 0.03 mg DROSPIRENONE 3 mg
FILM-COATED TABLET
ETHINYLESTRADIOL 0.03 mg DROSPIRENONE 3 mg
POM
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
Withdrawn
2017-06-20
1 PACKAGE LEAFLET: INFORMATION FOR THE USER JULIA 0.03 MG/3 MG FILM-COATED TABLETS Ethinylestradiol and drospirenone IMPORTANT THINGS TO KNOW ABOUT COMBINED HORMONAL CONTRACEPTIVES (CHCS): • They are one of the most reliable reversible methods of contraception if used correctly • They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive following a break of 4 or more weeks • Please be alert and see your doctor if you think you may have symptoms of a blood clot (see section 2 “Blood clots”) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effect, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Julia is and what it is used for 2. What you need to know before you use Julia 3. How to take Julia 4. Possible side effects 5. How to store Julia 6. Contents of the pack and other information 1. WHAT JULIA IS AND WHAT IT IS USED FOR - Julia is a contraceptive pill and is used to prevent pregnancy. - Each tablet contains a small amount of two different female hormones, namely drospirenone and ethinylestradiol. - Contraceptive pills that contain two hormones are called “combination” pills. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE JULIA GENERAL NOTES Before you start using Julia you should read the information on blood clots in section 2. It is particularly important to read the symptoms of a blood clot – see Section 2 “Blood clots”. Before you can begin taking Julia , your doctor will ask you some questions about your personal health history Lire le document complet
Page 1 of 17 1. NAME OF THE MEDICINAL PRODUCT Julia 0.03 mg /3 mg film-coated tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 0.03 mg ethinylestradiol and drospirenone 3 mg. Excipients with known effect: Each film-coated tablet contains 49.77 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Yellow, round, biconvex film-coated tablet with “30” on one side. The other side is without engraving. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Oral contraception. The decision to prescribe Julia should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Julia compares with other combined hormonal contraceptives (CHCs) (see sections 4.3 and 4.4). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Route of administration: oral use HOW TO TAKE JULIA The tablets must be taken every day at about the same time, if necessary with a little liquid, in the order shown on the blister pack. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free interval, during which time a withdrawal bleed usually occurs. This usually starts on day 2-3 after the last tablet and may not have finished before the next pack is started. HOW TO START JULIA - No preceding hormonal contraceptive use (in the past month) Tablet-taking has to start on day 1 of the woman's natural cycle (i.e. the first day of her menstrual bleeding). - Changing from another combined hormonal contraceptive (combined oral contraceptive (COC), vaginal ring or transdermal patch) The woman should start with Julia preferably on the day after the last active tablet (the last tablet containing the active substances) of her previous COC, but at the latest on the day following the usual Page 2 of 17 tablet-free or placebo tablet interval of her previous COC. In case a vaginal ring or transdermal patch has been used, the wom Lire le document complet